Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA Pushing For Studies of Drug Side Effects for Children August 27, 2013 Martha Garcia Add Your Comments Federal health regulators say they plan to use new tools and authorities granted by Congress to push drug companies to test their drugs for potential side effects on children when necessary, and help prevent any testing that would put children at unnecessary risk. The FDA vowed renewed commitment to studying drug side effects for children, according to a new FDA blog post. The agency hopes to do so thanks to a law that was reauthorized last year by Congress, giving the agency new tools to achieve its drug testing goals. However, it is unclear whether the laws provide the agency with any teeth to force companies to comply. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Dr. Lynne Yao, associate director of Pediatric and Maternal health Staff at the FDA, announced the agency’s goals and intentions on August 26. Yao focused on law changes that promote studies of children’s pharmaceuticals. She points out in the blog that many children currently use medications intended for adults, which have not been confirmed as safe for children. Yao also notes that many drugs That are effective in adults may not be effective in children, but are still promoted for childhood use. Children often require different dosages than adults; a fact which may often be overlooked when medications are prescribed for juvenile patients. Congress recently reauthorized and strengthened two laws which are supposed to aid the FDA in an effort to ensure more drug studies are conducted on pediatric patients. The Best Pharmaceuticals for Children Act (BPCA) offers incentives to pharmaceutical companies who conduct pediatric studies of certain medications. By conducting the FDA-requested studies, the companies earn an additional six months of marketing exclusivity in return. The Pediatric Research Equity Act (PREA) will require companies to study certain pediatric drugs under certain circumstances. When a pediatric study is required, the PREA ensures the same drug is studied in children for the same use it is prescribed for adults. The act can also allow drug manufacturers to forgo certain pediatric studies. For example, if a drug is used to treat a disease which only occurs in adults, such as prostate cancer. Under the acts, which were reauthorized under the FDA Safety and Innovation Act (FDASIA), the FDA may grant extensions on certain pediatric studies. As a part of this program the FDA will send non-compliance letters to the companies which fail to conduct the studies by a specified date. The FDA will also publish the name of the companies in violation along with the violation letters on its website. Health officials estimate nearly 80% of all medications approved for adults were also being used by children. Since Congress originally enacted BPCA and PREA in 2003, the rate has dropped to 50%. FDA Publishes Violation Letters The FDA published the first violation letters this week on a new web page. They include non-compliance letters for Genzyme Corp., Amedra Pharmaceuticals LLC and The Medicines Co. The letters state the companies failed to satisfy their obligations to conduct pediatric studies on approved children’s medications. However, the agency can only label a drug misbranded if the studies are not conducted. They cannot remove FDA approval. In question is whether the agency can levy fines or take any other punitive actions beyond a public scolding in the letters. The medications in question include kidney drugs, allergy and anaphylaxis medication and blood pressure medication, all drugs being used by children. The studies for these drugs were supposed to have been finished nearly seven years ago, in some cases, but remain incomplete. In each case, the companies failed to apply for an extension for permission to finish the studies. However, while the letters give the companies 45 days to respond, they do not mention any penalty if they fail to do so, and it is unclear what next steps the agency would take if the companies remain out of compliance. The FDA’s renewed efforts concerning the safety of pediatric drugs come following recent studies which reveal the medications used on adults offer detrimental effects in children. Most recently, a study published this month in JAMA Psychiatry found children who use antipsychotic medications such as Risperdal and Zyprexa had three times the risk of developing type 2 diabetes during the first year of use. The study was conducted after a government investigation was launched concerning the increasing number of children being prescribed antipsychotic medications intended for adults. Concerns have also been raised about the use of some of the medications among young boys, as side effects of Risperdal have been linked to male breast growth, including a serious medical condition known as gynecomastia, which often causes a serious impact on the child’s quality of life and may result in the need for surgical breast removal. Johnson & Johnson faces a growing number of Risperdal breast growth lawsuits filed in courts throughout the country, which allege that the drug maker failed to adequately warn users or the medical community about the risk of boys developing breasts following use of the medication. These problem are often misdiagnosed as weight gain associated with the medication, but in some cases boys have developed breasts measuring as large as a 38D cup size after using the medication. Tags: Antipsychotics, Childrens Drug, Risperdal More Lawsuit Stories Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study July 11, 2025 Cancer-Causing PFAS Water Contamination in 98% of Tested Sites in U.S.: Report July 11, 2025 Lawsuit Alleges Risperdal, Zyprexa Caused Breast Cancer Diagnosis July 11, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (Posted: yesterday) Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025) Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: 2 days ago) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)Uber Seeks To Transfer MDL Sexual Assault Lawsuits to Districts Where Attacks Occurred for Trial (05/23/2025) Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: 3 days ago) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)
Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (Posted: yesterday) Canadian researchers say receiving Depo-Provera injections for more than a year triples the risk of brain tumors compared to women who take birth control pills. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)
Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: 2 days ago) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)Uber Seeks To Transfer MDL Sexual Assault Lawsuits to Districts Where Attacks Occurred for Trial (05/23/2025)
Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (Posted: 3 days ago) A U.S. District Judge has ordered women involved in Depo-Provera lawsuits to inform him of any third-party pre-settlement loans they take out, as predatory interest rates may force them to reject settlement offers. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)